UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Daewoong launches BTX in Canada
by Lee Han-soo
2019-10-18 14:31
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech
by Lee Han-soo
2019-10-17 17:59
US sales of Remicade drop due to biosimilar’s rise
by Jeong Sae-im
2019-10-17 13:32
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
by Lee Han-soo
2019-10-16 18:22
‘New drug approval process takes about 300 days in Korea’
by Lee Han-soo
2019-10-16 15:06
라인
Merck Korea forcefully shuts down general medicine biz
by Kim Yun-mi
2019-10-15 15:51
Galderma Korea’s key strategy: choice and concentration
by Kim Yun-mi
2019-10-15 13:56
Medytox, Daewoong still in dispute over Nabota's spore appraisal
by Lee Han-soo
2019-10-15 11:28
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients
by Lee Han-soo
2019-10-14 18:01
HanAll's Chinese partner ends P2 trial of dry eye treatment
by Lee Han-soo
2019-10-14 14:08
라인
[Special] How are Korean employees coping with big-pharma M&As?
by Kim Yun-mi
2019-10-14 13:45
Sanofi releases data showing improved survival for prostate cancer treatment
by Lee Han-soo
2019-10-14 12:16
Regulator keeps Kolon Tissuegene listed with 1-year grace period
by Lee Han-soo
2019-10-12 09:41
GC to market Merck's diabetes treatment
by Lee Han-soo
2019-10-11 18:13
Bayer drugs out of stock in Korea
by Lee Han-soo
2019-10-11 16:36
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
by Kim Yun-mi
2019-10-11 15:13
Takeda Korea’s labor union goes on strike
by Lee Han-soo
2019-10-11 14:33
Roche’s Tecentriq combo therapy shows encouraging results
by Lee Han-soo
2019-10-10 17:36
Yuyu confirms safety of its antiplatelet drug
by Lee Han-soo
2019-10-10 17:35
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’
by Kim Yun-mi
2019-10-10 16:01
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top